Update on Imaging of Vulvar Squamous Cell Carcinoma
- 1 July 2013
- journal article
- review article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 201 (1), W147-W157
- https://doi.org/10.2214/ajr.12.9594
Abstract
OBJECTIVE. The purpose of this article is to describe the advantages and diagnostic and prognostic implications of imaging in the management of vulvar carcinoma. CONCLUSION. As the treatment of vulvar carcinoma evolves to tailored surgery and chemoradiation therapy to reduce morbidity, the importance of pretreatment assessment of vulvar carcinoma increases. Advances in imaging, such as pelvic MRI and PET, add to the benefits of clinical evaluation in pretreatment planning, assessment of response to chemoradiation therapy, and posttreatment surveillance.Keywords
This publication has 36 references indexed in Scilit:
- Current Management of Vulvar CancerHematology/Oncology Clinics of North America, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Clinical management of primary vulvar cancerEuropean Journal of Cancer, 2011
- Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulvaCritical Reviews in Oncology/Hematology, 2011
- Revised FIGO staging for carcinoma of the vulvaInternational Journal of Gynecology & Obstetrics, 2009
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometriumInternational Journal of Gynecology & Obstetrics, 2009
- New aspects of vulvar cancer: Changes in localization and age of onsetGynecologic Oncology, 2008
- Magnetic resonance imaging of vaginal and vulval pathologyEuropean Radiology, 2008
- Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancerCritical Reviews in Oncology/Hematology, 2006
- Carcinoma of the VulvaObstetrics & Gynecology, 2006